Manager TitleAgeSince
President - -
Corporate Secretary - -
Treasurer - 2020-02-09
Director TitleAgeSince
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
2/10/20 Tender

Chief Operating Officer

515,206 0.6781%
2/10/20 Tender

Director

44,537 0.0586%
2/10/20 Tender

Chairman

49,657 0.0654%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 302M
-0.86%+3.34%-21.79%-26.75% 16.03B
+0.42%+5.87%-26.48%-32.90% 7.4B
-1.16%-0.02%-21.62%-5.79% 6.26B
+0.13%+4.36%-6.11%-29.94% 4.08B
+1.00%+3.23%-22.46%-43.73% 3.32B
-1.46%+2.45%+8.21%-34.41% 3.18B
+1.37%+3.90%-41.35%-21.77% 3.12B
-0.51%+2.07%-10.53%+7.46% 2.7B
-4.05%-2.27%+94.44% - 2.5B
Average -0.50%+2.83%-5.30%-23.48% 5.4B
Weighted average by Cap. -0.53%+4.31%-13.89%-24.59%
Logo Diplomat Pharmacy, Inc.
Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company's primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company's patient care system is used to coordinate and track patient adherence and safety.
Employees
-
  1. Stock Market
  2. Stocks
  3. DPLO Stock